Daily Bulletin

Men's Weekly

.

Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

– In a dual-review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement based on a favorable clinical and cost-effectiveness comparison –

DUBLIN and LAKEWOOD, Colo., Oct. 28, 2021 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, and...

Read more: Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia...

Business News

Digital Marketing Agency in Sydney: Empowering Businesses with Smart Online Growth Strategies

Sydney’s business scene is fast-paced, diverse, and incredibly competitive. In such a dynamic environment, having a strong online presence is no longer optional — it’s essential. A digital marketing...

Daily Bulletin - avatar Daily Bulletin

Why Your Business Might Already Be a Cybercrime Target Without Knowing It

Cybercrime isn’t just something that happens to banks or large technology companies. It can happen to any business, even those that seem too small to matter. When a hacker sees an easy target, they ta...

Daily Bulletin - avatar Daily Bulletin

Car Rental as a Practical and Flexible Solution for Travel or Work

The contemporary, hectic way of life is one of ease and adaptability while commuting and working. Regardless of whether one moves around by road, commuting between towns for conferences, or taking a f...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business